Chris Baugh/LinkedIn
Oct 2, 2026, 11:20
Chris Baugh: Modern ED Strategies for Antithrombotic-Associated Bleeding
Chris Baugh, Chair Elect at Emergency Medicine Foundation, shared a post on LinkedIn:
“New paper in EB Medicine’s Emergency Medicine Practice: ‘Antithrombotic-Associated Bleeding: Management in the Emergency Department,’ co-authored with the incredibly talented Xin Qi and Annie Leamon.
Several points from the review that may change bedside practice:
- Resuscitation and hemorrhage control come first. Reversal runs in parallel and is not the initial priority.
- A normal INR or PTT does not exclude a DOAC effect. Drug-specific anti-factor Xa levels are needed, and a normal thrombin time effectively rules out a clinically significant dabigatran effect.
- Emergent warfarin reversal requires 4F-PCC plus IV vitamin K. Vitamin K alone is insufficient.
- With andexanet withdrawn from the US market, PCC-based replacement is the current strategy for factor Xa inhibitor reversal, though evidence for it remains limited.
- For antiplatelet-associated ICH, platelet transfusion is supported only when neurosurgical intervention is planned. In nonsurgical ICH, it offers no benefit and may cause harm.
- High thrombotic risk, such as a mechanical valve, does not automatically justify or preclude reversal. The decision weighs both risks.
The issue also covers periprocedural management, pregnancy, fibrinolytic reversal, and a clinical pathway for ED use.
It is eligible for 4 AMA PRA Category 1 Credits.”
Stay updated with Hemostasis Today.
-
Nov 20, 2026, 06:29Markus Müller: ABO Blood Groups and the Rare Bombay Phenotype
-
Nov 20, 2026, 05:57Lance Reed: Specialized Blood Components and Clinical Samples for Research and Diagnostics
-
Nov 20, 2026, 05:41Sundas Anjum: Community Engagement and Blood Donation for Thalassemia Care
-
Nov 20, 2026, 05:24A Celebration of Unity and Dedication in Hemophilia Care – Hemophilia Society Mumbai Chapter
-
Nov 20, 2026, 05:09Farhad Sheikh: Prasugrel vs Ticagrelor in Acute Coronary Syndromes
-
Nov 20, 2026, 05:02Jason Acker: Appointed as the Next Editor-in-Chief of Vox Sanguinis
-
Nov 20, 2026, 04:58Sabri Kemahli: International Society of Hematology Celebrates 80 Years of Hematology with Special Webinar
-
Nov 20, 2026, 04:46Alessandra Bosch: Swiss Haemophilia Network Wins Research Grant
-
Nov 20, 2026, 04:41Courtney Lawrence: HLA Antibodies and Platelet Transfusion Refractoriness in Hispanic Patients